What is Haemonetics Corporation's stock symbol?
Haemonetics Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "HAE."
Where is Haemonetics Corporation's stock going? Where will Haemonetics Corporation's stock price be in 2017?
9 brokerages have issued 12 month target prices for Haemonetics Corporation's shares. Their forecasts range from $24.00 to $41.00. On average, they expect Haemonetics Corporation's stock price to reach $34.57 in the next twelve months.
When will Haemonetics Corporation announce their earnings?
Haemonetics Corporation is scheduled to release their next quarterly earnings announcement on Monday, May, 1st 2017.
Who owns Haemonetics Corporation stock?
Haemonetics Corporation's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (3.25%), State Street Corp (2.27%), Franklin Resources Inc. (1.92%), Renaissance Technologies LLC (1.72%), Martingale Asset Management L P (0.35%) and FMR LLC (0.34%). Company insiders that own Haemonetics Corporation stock include Brian Concannon, Byron Selman, Christopher J Lindop, Christopher Simon, Jonathan White, Peter M Allen, Ronald G Gelbman, Ronald Merriman, Sandra Jesse, Susan Bartlett Foote and Susan M Hanlon.
Who sold Haemonetics Corporation stock? Who is selling Haemonetics Corporation stock?
Haemonetics Corporation's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Bogle Investment Management L P DE, Dimensional Fund Advisors LP, AQR Capital Management LLC, State Board of Administration of Florida Retirement System, Metropolitan Life Insurance Co. NY, Systematic Financial Management LP and Teachers Retirement System of The State of Kentucky. Company insiders that have sold Haemonetics Corporation stock in the last year include Ronald G Gelbman and Ronald Merriman.
Who bought Haemonetics Corporation stock? Who is buying Haemonetics Corporation stock?
Haemonetics Corporation's stock was bought by a variety of institutional investors in the last quarter, including State Street Corp, Russell Investments Group Ltd., Martingale Asset Management L P, Cigna Investments Inc. New, Tudor Investment Corp Et Al, Renaissance Technologies LLC, Numeric Investors LLC and Bayesian Capital Management LP.
How do I buy Haemonetics Corporation stock?
Shares of Haemonetics Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Haemonetics Corporation stock cost?
One share of Haemonetics Corporation stock can currently be purchased for approximately $37.50.